People · Operator
Named in public records as an officer, director or promoter · active 2010–2020 · Pharmaceuticals, Other Technology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Adynxx, Inc. | — | Pharmaceuticals | Series B | $21.5M | $544.1M | 2010 |
| SiteOne Therapeutics, Inc. | — | Pharmaceuticals | Series A | $16.1M | $460.3M | 2015 |
| ATX Innovation, Inc. | — | Other Technology | Seed | $9.9M | $119.6M | 2010 |
| Real Savvy, Inc. | — | Other Technology | Seed | $4.5M | $35.8M | 2014 |
| Exalys Therapeutics, Inc. | — | Pharmaceuticals | Series A | $4.0M | $123.9M | 2020 |
Rick Orr at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Rick Orr on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Dennis Podlesak | 2 | 6 |
| Stan Abel | 2 | 3 |
| Scott Sandell | 1 | 19 |
| Heath Lukatch | 1 | 10 |
| Joseph Zakrzewski | 1 | 6 |
| Lynne Rollins | 1 | 5 |
| Eckard Weber, M.D. | 1 | 5 |
| Will Price | 1 | 4 |
| Scott Harris | 1 | 4 |
| NICOLE VITULLO | 1 | 4 |
| Lowell E. Sears | 1 | 4 |
| Paul Fiore | 1 | 4 |
| Michael Sanders | 1 | 3 |
| Eckard Weber | 1 | 3 |
| Lowell Sears | 1 | 3 |
| James Treybig | 1 | 3 |
| Brian Taylor Slingsby | 1 | 2 |
| Justin DuBois | 1 | 1 |
| George Miljanich | 1 | 1 |
| David G Lemley | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.